Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03149822Phase 1/2Completed
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
PrincipalinvestigatorStart date: 2017-09-28
NCT01992016Not ApplicableCompleted
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
PrincipalinvestigatorStart date: 2014-04-07

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03149822Phase 1/2PrincipalInvestigator

Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
Completed
NCT01992016Not ApplicablePrincipalInvestigator

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
Completed
NCT01845792Phase 2PrincipalInvestigator

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

Prostate Cancer
Terminated

All 3 trials loaded